Navigation Links
Functional Imaging Supports Improved Cognition in Parkinson’s Disease Patients After REHACOP
Date:2/26/2017

Functional imaging data supports improved cognition in Parkinson’s disease (PD) patients after receiving cognitive rehabilitation, according to a study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress.

It is already known that cognitive rehabilitation programs are proven to be effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao et al., investigated structural and functional cerebral changes associated with cognitive rehabilitation in PD.

The study randomly divided 42 PD patients into a control and an experimental group, which received REHACOP, a cognitive rehabilitation program commonly used in psychosis and schizophrenia. The control group received only occupational activities. After treatment, the experimental group showed significant improvements in cognition and functional disability compared to the control group. While no significant structural changes were found between pre- and post-treatment, significant functional cerebral changes in PD patients was seen through resting-state and memory task-related fMRI.

Peter Schmidt, Senior Vice President and Chief Mission Officer at the National Parkinson Foundation, states, “Cognitive change is often the greatest concern for people with Parkinson’s, and we have seen in several studies that cognitive interventions can make a difference in patient outcomes. This study by Dr. Ibarretxe-Bilbao and colleagues takes this to the next step by providing insight into the mechanisms. While improving functional outcomes is our end goal, the best insight into how to optimize them usually comes from understanding the underlying biology. This analysis represents a significant contribution by linking the clinical benefits of a novel intervention to the changes in functional imaging.”

About the 1st Pan American Parkinson’s and Movement Disorders Congress: Meeting attendees gather to learn about the latest research findings and relevant issues in the field of Movement Disorders specific to North, Central and South America. Over 400 physicians and medical professionals will be able to view over 150 scientific abstracts submitted by clinicians from the Pan American region and throughout the world.

About the International Parkinson and Movement Disorder Society: The International Parkinson and Movement Disorder Society (MDS), an international society of over 5,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about MDS, visit http://www.movementdisorders.org.

Read the full story at http://www.prweb.com/releases/2017/02/prweb14099706.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Ivalua Buyer V8 Launch: Many Functional Enhancements, Even Greater Setup Flexibility and a Simplified Interface
2. MDeverywhere Releases Practice 1st Version 3.2, Its Revolutionary Practice Management and Revenue Cycle Software Application, Including ICD-10 Functionality and Sandbox
3. New Infographic Explains Private Exchange Functionality and Future of Defined Contribution Funding Model
4. How to Get a Lean and Functional Body with the Lean Hybrid Muscle – Vinamy
5. Functional Printing Market (Substrate, Inks) Worth $13.79 Billion by 2020 - New Report by MarketsandMarkets
6. KORT Physical Therapists Now Utilizing the Selective Functional Movement Assessment to Develop a More Comprehensive Treatment Plan for Patients
7. KeeboMed Inc. Introduces Live Chat Functionality on Its Website UsedUltrasoundEquipment.com
8. Functional electrical stimulation improves neuronal regeneration after cerebral infarction
9. Functional nerve cells from skin cells
10. UCI researchers identify new functional roles on cell surfaces for estrogen
11. Lutheran Services in Iowa Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution; Benefits from Labor Costing Functionality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), creator ... tool, and the Cancer Patient Education Network (CPEN), an independent professional organization that ... new strategic alliance. , As CPEN’s strategic partner, HLI will help support ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: